Coca-Cola Bottling Co. Consolidated
COKE
$172.23
+1.15%
Coca-Cola Consolidated, Inc. is a major independent bottler and distributor of non-alcoholic beverages in the United States, operating within the Consumer Defensive sector. The company's core business involves the manufacturing, marketing, and distribution of a wide portfolio of sparkling and still beverages, with its principal product being Coca-Cola, alongside energy drinks, bottled water, tea, coffee, and juices. As a key anchor in the Coca-Cola bottling system, it holds a distinct competitive identity as a large-scale, geographically focused operator with significant control over its distribution territories. The current investor narrative is likely shaped by its recent strong financial performance, including robust revenue growth and substantial free cash flow generation, as well as its strategic capital allocation decisions, such as aggressive share repurchases, which have significantly reduced share count and impacted its capital structure.…
COKE
Coca-Cola Bottling Co. Consolidated
$172.23
COKE 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Coca-Cola Bottling Co. Consolidated's 12-month outlook, with a consensus price target around $223.90 and implied upside of +30.0% versus the current price.
Average Target
$223.90
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$138 - $224
Analyst target range
Insufficient analyst coverage available. Only one analyst provides estimates, with a consensus revenue estimate of $7.228 billion, but no EPS estimates or price targets are provided. The institutional ratings data is outdated, with the last action from Citigroup in 2016. This limited coverage is typical for a mid-cap company like COKE, which, despite its $13.5 billion market cap, may fly under the radar of many large institutional research firms. The implication is that the stock may experience less efficient price discovery and higher volatility due to lower institutional scrutiny and liquidity, making it more susceptible to sharp moves based on company-specific news or quarterly results rather than analyst-driven expectations.
Bulls vs Bears: COKE Investment Factors
The bull and bear cases for COKE are sharply defined by its aggressive financial strategy. The bullish thesis is anchored in powerful fundamental metrics: massive free cash flow generation ($620.3M TTM), strong and stable margins (13.15% operating margin), and a forward P/E of just 4.37x that prices in a transformative earnings boost from share repurchases. The bearish thesis focuses on the extreme financial risk created by that very strategy, resulting in negative shareholder equity (D/E of -4.06) and a stock price that has retreated 22.5% from its 52-week high amid recent technical weakness. Currently, the bull case holds stronger evidence due to the concrete, high-quality profitability and cash flow metrics, but the bearish risks are severe and non-trivial. The single most important tension in the investment debate is whether the company's exceptional cash-generating ability can sustainably service its leveraged capital structure and justify its valuation, or if the negative equity and recent price reversal signal an impending re-rating of risk.
Bullish
- Exceptional Free Cash Flow Generation: The company generated $620.3 million in TTM free cash flow, a massive sum relative to its $13.5B market cap. This provides significant financial flexibility for debt repayment, dividends, and continued aggressive share repurchases, which directly enhance per-share value.
- Strong and Expanding Profitability: Gross margins are robust at 38.21% (Q4) and operating margins are healthy at 12.89%. Full-year operating margin stands at 13.15%, demonstrating efficient cost control and pricing power within its defensive beverage segment, supporting consistent earnings.
- Attractive Forward Valuation: The forward P/E ratio of 4.37x is exceptionally low, implying a dramatic earnings surge is priced in. This deep discount to the trailing P/E of 19.79x suggests significant potential for multiple expansion if the company meets or exceeds earnings expectations post-buyback.
- Aggressive Capital Return via Buybacks: The company repurchased $2.46 billion worth of stock in Q4 2025, drastically reducing share count. This action is a powerful signal of management's confidence and directly boosts EPS, a key driver behind the low forward P/E.
Bearish
- Extreme Financial Leverage & Negative Equity: The balance sheet shows negative shareholder equity and a debt-to-equity ratio of -4.06, a result of funding massive buybacks with debt. This creates a high-risk capital structure where any operational misstep could strain liquidity and amplify losses.
- Valuation Disconnect and Technical Weakness: The stock is down 9.17% over the past month with a -14.77 relative strength, signaling a sharp reversal from its 52-week high of $219.65. This technical breakdown, coupled with a trailing P/E of 19.79x that is in the upper-mid range of its historical band, suggests the stock may be overvalued after its recent run-up.
- Revenue Growth Shows Volatility: While Q4 2025 revenue grew 9.03% YoY, sequential quarterly revenue in 2025 showed volatility, with Q3 ($1.888B) dipping slightly from Q2 ($1.856B). This inconsistency raises questions about the sustainability of top-line growth in a mature industry.
- High Short Interest and Low Analyst Coverage: A short ratio of 4.56 indicates significant bearish sentiment and potential for squeezes or heightened volatility. Furthermore, minimal analyst coverage (only one providing revenue estimates) leads to less efficient price discovery and higher susceptibility to sharp, sentiment-driven moves.
COKE Technical Analysis
The stock is in a sustained long-term uptrend, evidenced by a 1-year price change of +46.47%, significantly outperforming the SPY's +25.19% gain. However, the current price of $170.27 sits at approximately 56.8% of its 52-week range ($105.21 to $219.65), indicating a substantial retreat from recent highs and positioning the stock in a middle-ground area that suggests neither extreme momentum nor deep value after a notable correction. Recent momentum has turned sharply negative, with the stock down 9.17% over the past month and showing a relative strength of -14.77 against the market, which contrasts starkly with its strong 3-month gain of +5.16%. This divergence signals a significant near-term pullback or profit-taking phase within the broader uptrend, potentially triggered by the stock's rapid ascent to its 52-week high in March 2026. Key technical support is anchored at the 52-week low of $105.21, while immediate overhead resistance is at the recent 52-week high of $219.65. A decisive break above the $219.65 level would signal a resumption of the powerful bull trend, whereas a breakdown below the $105.21 support would indicate a major trend reversal. The stock exhibits a beta of 0.601, meaning it is approximately 40% less volatile than the broader market (SPY), which is atypical for a mid-cap stock and suggests it has behaved as a defensive holding, though recent price swings, including a max drawdown of -25.34%, highlight periods of significant idiosyncratic movement. The price action shows extreme volatility, with the stock rocketing from around $150 in early February 2026 to over $216 by mid-March, only to collapse back to the $170s by May. This whipsaw behavior, coupled with a high short ratio of 4.56, indicates a battleground stock with heightened sentiment swings. The sharp decline from the highs suggests the market is digesting the prior massive rally, and the current level may represent a consolidation zone before the next directional move.
Beta
0.60
0.60x market volatility
Max Drawdown
-25.3%
Largest decline past year
52-Week Range
$105-$220
Price range past year
Annual Return
+46.5%
Cumulative gain past year
| Period | COKE Return | S&P 500 |
|---|---|---|
| 1m | -9.4% | +4.0% |
| 3m | +3.7% | +8.2% |
| 6m | +5.2% | +11.5% |
| 1y | +46.5% | +24.3% |
| ytd | +14.9% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
COKE Fundamental Analysis
Revenue growth remains healthy but has shown some quarterly volatility. For Q4 2025 (ending Dec 31), revenue was $1.904 billion, representing a solid 9.03% year-over-year growth. Segment data reveals the Nonalcoholic Beverage segment drove nearly all revenue at $1.893 billion, with the 'All Other' segment contributing a minimal $83.1 million. Examining sequential quarters in 2025, revenue grew from $1.580 billion in Q1 to $1.906 billion in Q4, indicating a generally upward trajectory, though Q3 revenue of $1.888 billion was slightly below Q2's $1.856 billion, suggesting potential seasonality or minor deceleration. The company is highly profitable with expanding margins. Q4 2025 net income was $137.3 million, yielding a net margin of 7.21%. Gross margin for the quarter was a robust 38.21%, consistent with the full-year gross margin of 39.74% from valuation data. More importantly, operating margins are strong at 13.15% (full-year) and 12.89% (Q4), demonstrating efficient cost control. Profitability is further evidenced by a positive Return on Assets (ROA) of 12.70%, though a negative Return on Equity (ROE) of -77.13% is an anomaly driven by negative shareholder equity on the balance sheet. The balance sheet presents a unique situation with negative shareholder equity (-$4.06 debt-to-equity ratio), largely due to aggressive share buybacks funded by debt and cash flow, as seen in the $2.46 billion stock repurchase and $996 million debt repayment in Q4 2025. Despite this, liquidity is adequate with a current ratio of 1.26. Crucially, the company generates massive free cash flow, with TTM FCF at $620.3 million, providing ample internal funding for growth, dividends ($0.21 million paid in Q4), and further capital returns. The strong FCF, coupled with a high interest coverage ratio of 9.75, mitigates the financial risk implied by the negative equity position.
Quarterly Revenue
$1.9B
2025-12
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.38%
Latest Quarter
Free Cash Flow
$620252000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is COKE Overvalued?
Given the company's substantial positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 19.79x, while the forward PE is significantly lower at 4.37x. This substantial gap implies the market expects a dramatic surge in earnings over the next twelve months, likely factoring in the full-year impact of reduced share count from buybacks and sustained operational performance. Comparing to industry averages is challenging due to missing sector-specific multiples in the provided data. However, a trailing PE of 19.79x for a defensive beverage bottler with mid-single-digit revenue growth appears reasonable, if not slightly elevated, unless justified by superior margin profile or market position. The Price-to-Sales ratio of 1.56x and EV-to-Sales of 0.35x seem low, potentially indicating the market is valuing the company's revenue stream conservatively or that the capital structure (negative equity) is distorting enterprise-based multiples. Historically, the stock's own PE ratio has fluctuated significantly. The current trailing PE of 19.79x is above the levels seen in 2023 (ranging from 10.14x to 28.69x) and early 2024 (around 15.38x), but below the peak of 27.98x in Q1 2025. This places the current valuation in the upper-mid range of its recent historical band, suggesting the market has priced in a good portion of the positive earnings trajectory but may not be at peak optimism, especially considering the forward PE's deep discount.
PE
19.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 8x~76x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.0x
Enterprise Value Multiple
Investment Risk Disclosure
Paragraph 1 — Financial & Operational Risks: The primary financial risk stems from an extremely leveraged capital structure, with negative shareholder equity and a debt-to-equity ratio of -4.06, a direct result of funding $2.46 billion in share repurchases. While strong free cash flow ($620.3M TTM) and a healthy interest coverage ratio (9.75x) currently mitigate default risk, this structure leaves minimal margin for error. Any sustained downturn in revenue growth from its current ~9% YoY pace or compression in its robust 38.21% gross margin could quickly pressure cash flows needed to service debt, fund operations, and continue shareholder returns. The company's revenue is also highly concentrated, with 99.4% derived from its Nonalcoholic Beverage segment, creating significant operational concentration risk.
Paragraph 2 — Market & Competitive Risks: The stock faces valuation compression risk, as its trailing P/E of 19.79x sits in the upper-mid range of its own historical band (10.14x to 28.69x), suggesting limited multiple expansion potential after its 46.47% 1-year rally. As a defensive stock with a low 0.601 beta, it is susceptible to sector rotation out of consumer staples if investor sentiment shifts towards more cyclical growth sectors. Competitive risks are inherent in the mature non-alcoholic beverage market, where pricing pressure and shifting consumer tastes could erode its strong margins. The stock's recent extreme volatility, including a -25.34% max drawdown and a 9.17% decline over the past month, highlights its vulnerability to sentiment swings, exacerbated by low analyst coverage.
Paragraph 3 — Worst-Case Scenario: The worst-case scenario involves a perfect storm of operational missteps and a macro downturn. A significant miss on revenue growth or a sharp contraction in the 38.21% gross margin, combined with rising interest rates increasing its debt burden, could trigger a liquidity crisis given its negative equity. This could force a halt to the share repurchase program that has been propping up EPS, leading to multiple contraction. Analyst coverage is too sparse to provide a low target, but a realistic downside could see the stock re-testing its 52-week low of $105.21, representing a potential loss of approximately -38% from the current price of $170.27. Such a move would be catalyzed by an earnings miss, a guidance cut, or a credit rating downgrade.
